Literature DB >> 15528693

Evaluation of the BD PHOENIX automated microbiology system for detection of methicillin resistance in coagulase-negative staphylococci.

Matthias A Horstkotte1, Johannes K-M Knobloch, Holger Rohde, Sabine Dobinsky, Dietrich Mack.   

Abstract

The new BD PHOENIX automated microbiology system (Becton Dickinson Diagnostic Systems, Sparks, Md.) is designed for automated rapid antimicrobial susceptibility testing and identification of clinically relevant bacteria. In our study, the accuracy and speed of the BD PHOENIX oxacillin MIC determination for detecting methicillin resistance was evaluated for 200 clinical isolates of coagulase-negative staphylococci (CoNS). Compared to mecA PCR, the BD PHOENIX system detected methicillin resistance with a sensitivity of 99.2%. According to the actual NCCLS oxacillin MIC breakpoint of > or =0.5 microg/ml, the specificity was only 64.9%, attributable to false-positive results in 26 mecA-negative strains, including 16 non-Staphylococcus epidermidis strains. Alternative oxacillin breakpoints of > or =1, > or =2, and > or =4 microg/ml resulted in increased specificities of 83.8, 94.6, and 100% and high sensitivities of 99.2, 99.2, and 96.7%, respectively. Similarly, NCCLS broth microdilution oxacillin MICs exhibited a sensitivity of 100% but a low degree of specificity. However, the previous oxacillin MIC breakpoint of > or =4 microg/ml performed with a sensitivity of 98.4% and a specificity of 98.7%. BD PHOENIX oxacillin MIC results were available after 9 h for 40.5% of the examined CoNS strains and were completed after 17 h. Our results revealed the high reliability of the BD PHOENIX system as a phenotypic method for detection of resistance to oxacillin in mecA-positive CoNS. However, for the improvement of specificity, reevaluation of the optimal oxacillin MIC breakpoint for CoNS appears to be necessary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528693      PMCID: PMC525221          DOI: 10.1128/JCM.42.11.5041-5046.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

1.  Methods for improved detection of oxacillin resistance in coagulase-negative staphylococci: results of a multicenter study.

Authors:  F C Tenover; R N Jones; J M Swenson; B Zimmer; S McAllister; J H Jorgensen
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 2.  Vancomycin-resistant enterococcal infections.

Authors:  B E Murray
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

3.  Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci.

Authors:  Z Hussain; L Stoakes; V Massey; D Diagre; V Fitzgerald; S El Sayed; R Lannigan
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Rapid detection of mecA-positive and mecA-negative coagulase-negative staphylococci by an anti-penicillin binding protein 2a slide latex agglutination test.

Authors:  Z Hussain; L Stoakes; S Garrow; S Longo; V Fitzgerald; R Lannigan
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

5.  Establishing MIC breakpoints for coagulase-negative Staphylococci to oxacillin.

Authors:  J M Andrews; F J Boswell; R Wise
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

6.  National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000.

Authors: 
Journal:  Am J Infect Control       Date:  2000-12       Impact factor: 2.918

Review 7.  Infective endocarditis in adults.

Authors:  E Mylonakis; S B Calderwood
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

8.  Evaluation of screening and commercial methods for detection of methicillin resistance in coagulase-negative staphylococci.

Authors:  Z Hussain; L Stoakes; R Lannigan; S Longo; B Nancekivell
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

9.  Rapid detection of methicillin resistance in staphylococci using a slide latex agglutination kit.

Authors:  E E Udo; E M Mokadas; A Al-Haddad; B Mathew; L E Jacob; S C Sanyal
Journal:  Int J Antimicrob Agents       Date:  2000-06       Impact factor: 5.283

10.  Evaluation of a latex agglutination test (MRSA-Screen) for detection of oxacillin resistance in coagulase-negative Staphylococci.

Authors:  L Louie; A Majury; J Goodfellow; M Louie; A E Simor
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

View more
  5 in total

1.  Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of staphylococci and enterococci.

Authors:  Karen C Carroll; Anita P Borek; Chad Burger; Brian Glanz; Hasan Bhally; Susan Henciak; Diane C Flayhart
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 2.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Comparison of the BD Phoenix system with the cefoxitin disk diffusion test for detection of methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci.

Authors:  Antonella Mencacci; Ines Montecarlo; Francesca Gonfia; Amedeo Moretti; Angela Cardaccia; Senia Farinelli; Maria Rita Pagliochini; Angela Giuliani; Michela Basileo; Maria Bruna Pasticci; Francesco Bistoni
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

4.  Rapid detection of methicillin-resistant staphylococci by real-time PCR directly from positive blood culture bottles.

Authors:  S Gröbner; V A J Kempf
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

Review 5.  Current and emerging techniques for antibiotic susceptibility tests.

Authors:  Karan Syal; Manni Mo; Hui Yu; Rafael Iriya; Wenwen Jing; Sui Guodong; Shaopeng Wang; Thomas E Grys; Shelley E Haydel; Nongjian Tao
Journal:  Theranostics       Date:  2017-04-10       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.